460 results on '"Park, Yongwhi"'
Search Results
2. Different association of atherogenic index of plasma with the risk of high platelet reactivity according to the presentation of acute myocardial infarction
3. High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation
4. Long-acting cilostazol versus isosorbide mononitrate for patients with vasospastic angina: a randomized controlled trial
5. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
6. Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium
7. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
8. Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
9. Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
10. Long-term prognostic implications of brachial-ankle pulse wave velocity in patients undergoing percutaneous coronary intervention
11. Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions
12. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention
13. Comparative analysis of three nutrition scores in predicting mortality after acute myocardial infarction
14. Abstract 11427: Clot Strength and Platelet Reactivity for Prediction of Major Cardiovascular Events After Percutaneous Coronary Intervention
15. Head-to-head comparison of prognostic accuracy in patients undergoing noncardiac surgery of dobutamine stress echocardiography versus computed tomography coronary angiography (PANDA trial): A prospective observational study
16. Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis
17. Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
18. Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis
19. The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease
20. Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine
21. TCT-354 The Clinical Impact of Dual Antiplatelet Therapy Score Combined With P2Y12 Reactivity Unit on East Asian Patients Who Received Drug-Eluting Stent Implantation: PTRG-DES Consortium
22. TCT-2 Different Association of Plasma Atherogenicity Assessed by Atherogenic Index of Plasma With the Risk of High Platelet Reactivity According to the Presentation of Acute Myocardial Infarction
23. Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention
24. High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention.
25. Predictive value of the combination of brachial-ankle pulse wave velocity and ankle-brachial index for cardiovascular outcomes in patients with acute myocardial infarction
26. Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction
27. Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
28. Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study
29. Update on oral antithrombotic therapy for secondary prevention following non-ST segment elevation myocardial infarction
30. Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure
31. Efficacy and Safety of Moderate-Intensity Statin with Ezetimibe Combination Therapy in Patients after Percutaneous Coronary Intervention Results from the RACING Trial
32. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions
33. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention
34. Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
35. Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
36. Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation
37. TCT-31 Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent
38. TCT-30 Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients: Results From the PTRG-DES Consortium
39. TCT-592 Predictors of Incomplete Hemostasis After Transradial Coronary Intervention: A Prospective Cohort Study
40. TCT-29 Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients With Diabetes: Results From the PTRG-DES Registry
41. TCT-201 Linkage of Diabetic Status With Thrombogenic Indices and Its Prognostic Implication in Patients Undergoing Percutaneous Coronary Intervention
42. Door-to-balloon time and cardiac mortality in acute myocardial infarction by total occlusion of the left circumflex artery
43. Prognostic value of brachial-ankle pulse wave velocity in patients with non-ST-elevation myocardial infarction
44. Abstract 20526: Bleeding Episode Predicts the Occurrence of Dyspnea During Ticagrelor Treatment in Patients With Acute Coronary Syndrome
45. Abstract 20447: Platelet-Fibrin Clot Strength Predicts the Occurrence of Slow Coronary Flow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
46. Influence of platelet reactivity and inflammation on peri-procedural myonecrosis in East Asian patients undergoing elective percutaneous coronary intervention
47. Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
48. Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients With Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
49. Intravascular ultrasound guided recanalization of stumpless chronic total occlusion
50. The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.